A structural model of toxic amyloid oligomers involved in type 2 diabetes. [PDF]
Shivani ST +15 more
europepmc +1 more source
Cancer-Alzheimer inverse comorbidity from epidemiology to protein self-assembly. [PDF]
Zhang Y +4 more
europepmc +1 more source
Hybrid Insulin Peptides as Antigens and Tolerogens for Pathogenic T Cells in Autoimmune Diabetes. [PDF]
Haskins K +3 more
europepmc +1 more source
Targeting macrophage metabolism: mechanisms, cellular crosstalk and implications in obesity-associated metabolic diseases. [PDF]
Yao C +8 more
europepmc +1 more source
Primary Cilia as Integrative Hubs of Metabolic Signaling in Type 2 Diabetes: Inter-Organ Evidence From Central, Peripheral, and Pancreatic Islet Tissues. [PDF]
Liang M +11 more
europepmc +1 more source
The intrinsically disordered region of the human parathyroid hormone controls functional amyloid properties. [PDF]
Sachan S +7 more
europepmc +1 more source
Revitalizing GIP: Therapeutic Potential in Metabolic and Neurodegenerative Disorders. [PDF]
Qiao Y, Zhou F, Mao T, Gao L.
europepmc +1 more source
Glucagon-like Peptide-1 and Dual GIP/GLP-1 Receptor Agonists in Brain: Exploring the Expanding Role and Safety in Neuropsychiatry. [PDF]
Tudosie AC, Marin LM, Popa SG, Golli AL.
europepmc +1 more source
Inhibition of α-Glucosidase Activity and Islet Amyloid PolyPeptide Fibril Formation by <i>Rubus</i><i>ulmifolius</i> Fruit Extract: A Potential Therapeutic Approach for Type 2 Diabetes Mellitus. [PDF]
Floris S +12 more
europepmc +1 more source
Polymorphism of amyloid fibrils of a SARS-CoV-2 peptide associated with hemagglutination. [PDF]
Yamaguchi M, Hiroaki H, Hibino E.
europepmc +1 more source

